|
|
ARICEPT®
donepezil hydrochloride tablets"Bottles not actual size"

http://www.aricept.com
|
Aricept®, discovered and developed by Eisai and approved by the U.S. Food and Drug Administration (FDA) in 1996, is a once-a-day product to treat mild, moderate and severe Alzheimer's disease. Studies showed Aricept® treats Alzheimer's symptoms, slowing the loss of overall function and improving cognition. About 5 million people in the United States have Alzheimer's disease, a progressive brain disease that gradually destroys a person's memory and ability to learn, reason, make judgments, communicate and carry out daily activities. While there is no cure, the prescription medicine Aricept® is available to help manage symptoms of the disease.
Today, Aricept® is the number-one prescribed Alzheimer's medication worldwide. It is sold in approximately 75 countries. In the United States, the product is co-promoted by Eisai Inc. and Pfizer Inc and distributed by Eisai Inc. Aricept® continues to be studied for various potential new indications and formulations. For example, the recently approved Aricept ODT™ (donepezil HCl) Orally Disintegrating Tablets were designed to make administration easier for patients who have difficulty swallowing pills - the first such medication approved by the FDA to treat the symptoms of Alzheimer's.
Aricept® is well tolerated but may not be for everyone. People at risk for stomach ulcers or who take certain other medicines should tell their doctors becasue serious stomach problems, such as bleeding, may get worse. Some people who take Aricept® may experience fainting. Some people may have nausea, vomiting, diarrhea, bruising, or not sleep well. Some people may have muscle cramps or loss of appetite or may feel tired. In studies, these were usually mild and temporary.
For more information about managing Alzheimer's disease and about Aricept®, visit www.aricept.com or call 1-888-274-2378. If you are a US Healthcare Professional you may also search for more information at www.eisaimedicalinformation.com.
Package Insert: Aricept_23_mg_PI.pdf
|
| |
Printer Friendly Version
|
|
|